Cancer Council webinar: ‘Getting to the bottom of colonoscopy use in bowel screening’

Tuesday 6 September 2022
6:00pm – 7:00 PM (WST)

Speaker: Dr Hooi Ee, Gastroenterologist & Head of Department, Sir Charles Gairdner Hospital, Perth
Host: Dr Eleanora Feletto

Register here.

Encouragement and support by GPs and practice nurses, can have significant impact on improving participation in bowel cancer screening; evidence shows that a recommendation by a trusted health professional is a key motivator to participate. General practice health professionals have several important roles in the NBCSP, including encouraging and supporting participation, managing participants who have a positive FOBT, providing information about referrals to the NBCSP, and managing individuals who, by way of symptom(s) or significant family history, require diagnostic investigations or targeted surveillance rather than screening.

In this three-part webinar series, an array of experts from across Australia will present on various topics related to bowel cancer screening, including the latest research on those who do not screen and why; the National Bowel Cancer Screening program; and the importance of the appropriate use of colonoscopy . Part three, Gastroenterologist Dr Hooi Ee will discuss the appropriate use of colonoscopies including when to start and stop surveillance for patients; how to communicate the benefits and risk to patients, and when to refer a patient back to the National Bowel Cancer Screening Program after a colonoscopy.

On the morning of Tuesday 6 September an email will be sent to registered attendees which will contain a link to join the webinar. You will be able to join the webinar by clicking the link. Please note time the webinar will start at 6.00pm AWST, 7.30pm ACST, and 8.00pm AEST.

5 minutes – Welcome and introductions

40 minutes – Presentations

• Dr Hooi Ee – Gastroenterologist & Head of Department, Sir Charles Gairdner Hospital

15 minutes – Questions & discussion

Learning outcomes

• Recall how to communicate with patients the harm-to-benefit ratio of using colonoscopy for screening in average-risk populations
• Describe the appropriate use of surveillance colonoscopies including when they should be initiated and ceased.
• Identify when a patient who has had a colonoscopy can be referred back to the National Bowel Cancer Screening Program

This activity is pending accreditation under ACRRM PDP, and the RACGP CPD Program – Activity ID: 362240